DJIA 16,677.90 216.58 1.32%
NASDAQ 4,452.79 69.95 1.60%
S&P 500 1,950.82 23.71 1.23%
market minute promo

2.31 0.01 (0.43%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

PLX $2.31 0.43%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $2.36
Previous Close $2.30
Daily Range $2.25 - $2.40
52-Week Range $2.05 - $5.30
Market Cap $216.4M
P/E Ratio 8.52
Dividend (Yield) $0.00 (0.0%)
Volume 219,658
Average Daily Volume 515,090
Current FY EPS -$0.15

Sector

Healthcare

Industry

Drugs

Protalix BioTherapeutics, Inc. (PLX) Description

A clinical stage biopharmaceutical company that is focused on developing and manufacturing recombinant therapeutic proteins that are produced through its proprietary plant cell system. Website: http://www.protalix.com/

News & Commentary

3 High-Risk, High-Reward Biotech Stocks for Long Term Investors

Everyone wants to get rich, but investing in the wrong developmental companies can have disastrous consequences. Here are three companies with game-changing potential that have yet to hit their stride -- and may payoff in the long run.

Avago Technologies' Memory, FBAR, and Connectivity Business Will Take It Higher

5 Stocks Ready to Break Out and Soar Higher

Protalix BioTherapeutics, Inc. (PLX) in Focus: Stock Surges 11.4% - Tale of the Tape

How Protalix BioTherapeutics (PLX) Stock Stands Out in a Strong Industry - Tale of the Tape

How Protalix BioTherapeutics (PLX) Stock Stands Out in a Strong Industry - Tale of the Tape

Protalix/Pfizer's Elelyso Approved in Pediatric Patients - Analyst Blog

Protalix BioTherapeutics, Inc. (PLX) Jumps: Stock Adds 8.3% in Session - Tale of the Tape

Sector Update: Health Care Stocks Mostly Lower; Regulators OK Expanded Use of Protalix Medication fo

Sector Update: Health Care Stocks Mostly Lower; Regulators OK Expanded Use of Protalix Medication for Gaucher Disease

Sector Update: Health Care

Why Protalix BioTherapeutics (PLX) Stock Is Surging Today

3 Pharma Companies That Could Deliver Breakthroughs In 'Plantibody' Technology

See More PLX News...

PLX's Top Competitors

PLX $2.31 (0.43%)
Current stock: PLX
AMGN $147.25 (2.51%)
Current stock: AMGN
GILD $107.18 (1.03%)
Current stock: GILD
BIIB $316.06 (2.26%)
Current stock: BIIB